Canopy Growth Corporation Stock (CGC) Surges on Trump Marijuana Rescheduling Reports: Latest News, Forecasts, and What Comes Next (Dec. 15, 2025)
Canopy Growth shares surged as much as 17.9% in early European trading Monday, extending Friday’s 54% jump, after reports that President Trump may reclassify marijuana as a Schedule III drug. Trading volume spiked, with speculation focused on potential U.S. federal reform and its impact on cannabis industry taxes. No final decision has been confirmed by the White House.